Reduction of hypertension-associated heart disease and stroke among black Americans: past experience and new perspectives on targeting resources.
Over the past two decades, national hypertension-control programs and policies have focused on early diagnosis and management. Measured by intermediate results--such as percentages of cases now taking medication--these efforts have been markedly successful, especially among black hypertensives. The ultimate measure of success--reduction in hypertension-associated disease and death--must address the one-third excess prevalent among blacks. Biologic and age-specific variables in diagnosis and treatment must be accommodated. Future gains in efficient use of resources and equity in outcome will require use of new technologies and models of targeting.